绵羊失血性休克与复苏模型:评估组织氧输送与氧债偿还,指导患者血液管理
该研究建立绵羊失血性休克模型,通过分步静脉放血至平均动脉压(MAP)30 mm Hg、混合静脉血氧饱和度(SvO2)<60%、动脉乳酸>4 mM,再用PlasmaLyte®复苏至MAP>65 mm Hg。失血导致MAP、SvO2、脑与外周肌肉组织氧饱和度(StO2)下降、动脉乳酸升高、碱剩余下降;复苏后上述指标向基线恢复,但血红蛋白从基线10.8±1.2 g/dL降至复苏后5.9±1.1 g/dL(P<0.01)。作者认为无创组织氧输送与氧债偿还指标适合作为患者血液管理的结局指标,并可转化用于新型复苏策略的临床前评估。
要点
- 失血性休克模型以MAP 30 mm Hg、SvO2<60%、动脉乳酸>4 mM为休克诱导终点。
- 失血后外周肌肉StO2从66±8%降至16±9%(P<0.01),脑StO2从77±11%降至65±9%(P<0.01)。
- PlasmaLyte®复苏至MAP>65 mm Hg后,无创指标向基线恢复,但血红蛋白从10.8±1.2降至5.9±1.1 g/dL(P<0.01)。
- 作者认为无创组织氧输送与氧债偿还指标可用于指导失血性休克的患者血液管理。
适用人群与场景
- 雌性Dorset杂交绵羊,麻醉插管后用于失血性休克与复苏模型研究。
诊断标准与关键阈值
- 休克诱导标准:分步静脉放血直至MAP 30 mm Hg、SvO2<60%、动脉乳酸>4 mM。
- 复苏目标:MAP>65 mm Hg。
处置流程与药物剂量
- 以PlasmaLyte®进行复苏,剂量调整至MAP>65 mm Hg。
研究设计与关键结果
- 失血至休克期间:MAP从89±5降至31±5 mm Hg(P<0.01),SvO2从70±7%降至23±8%(P<0.05),脑组织StO2从77±11%降至65±9%(P<0.01),外周肌肉StO2从66±8%降至16±9%(P<0.01),动脉乳酸从1.5±1.0升至5.1±0.8 mM(P<0.01),碱剩余从1.1±2.2降至-3.6±1.7 mM(P<0.05)。
- 侵入性器官特异性监测证实组织氧输送减少;所有组织氧分压下降、乳酸升高,但脑组织变化较温和。
- PlasmaLyte®血容量替代后主要结局指标向基线改善,器官特异性指标证实;尽管血红蛋白从基线10.8±1.2 g/dL降至复苏后5.9±1.1 g/dL(P<0.01)。
证据类型、等级与局限
- 证据类型:动物实验(绵羊失血性休克模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为无创组织氧输送与氧债偿还指标适合作为失血性休克患者血液管理的结局指标,并可转化用于新型复苏策略的临床前评估。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Aggressive fluid or blood component transfusion for severe hemorrhagic shock may restore macrocirculatory parameters, but not always improve microcirculatory perfusion and tissue oxygen delivery. We established an ovine model of hemorrhagic shock to systematically assess tissue oxygen delivery and repayment of oxygen debt; appropriate outcomes to guide Patient Blood Management.
METHODS: Female Dorset-cross sheep were anesthetized, intubated, and subjected to comprehensive macrohemodynamic, regional tissue oxygen saturation (StO2), sublingual capillary imaging, and arterial lactate monitoring confirmed by invasive organ-specific microvascular perfusion, oxygen pressure, and lactate/pyruvate levels in brain, kidney, liver, and skeletal muscle. Shock was induced by stepwise withdrawal of venous blood until MAP was 30 mm Hg, mixed venous oxygen saturation (SvO2) < 60%, and arterial lactate >4 mM. Resuscitation with PlasmaLyte® was dosed to achieve MAP > 65 mm Hg.
RESULTS: Hemorrhage impacted primary outcomes between baseline and development of shock: MAP 89 ± 5 to 31 ± 5 mm Hg (P < 0.01), SvO2 70 ± 7 to 23 ± 8% (P < 0.05), cerebral regional tissue StO2 77 ± 11 to 65 ± 9% (P < 0.01), peripheral muscle StO2 66 ± 8 to 16 ± 9% (P < 0.01), arterial lactate 1.5 ± 1.0 to 5.1 ± 0.8 mM (P < 0.01), and base excess 1.1 ± 2.2 to -3.6 ± 1.7 mM (P < 0.05). Invasive organ-specific monitoring confirmed reduced tissue oxygen delivery; oxygen tension decreased and lactate increased in all tissues, but moderately in brain. Blood volume replacement with PlasmaLyte® improved primary outcome measures toward baseline, confirmed by organ-specific measures, despite hemoglobin reduced from baseline 10.8 ± 1.2 to 5.9 ± 1.1 g/dL post-resuscitation (P < 0.01).
CONCLUSION: Non-invasive measures of tissue oxygen delivery and oxygen debt repayment are suitable outcomes to inform Patient Blood Management of hemorrhagic shock, translatable for pre-clinical assessment of novel resuscitation strategies.
参考来源
- Dyer WB, Tung JP, Li Bassi G, et al. An Ovine Model of Hemorrhagic Shock and Resuscitation, to Assess Recovery of Tissue Oxygen Delivery and Oxygen Debt, and Inform Patient Blood Management. Shock. 2021. PMID: 34014886. doi:10.1097/SHK.0000000000001805
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。